SEC Comment Letter for QUESTCOR PHARMACEUTICALS INC (CIK 0000891288) — Sep 16, 2005

QUESTCOR PHARMACEUTICALS INC (CIK 0000891288)
Date: Sept. 16, 2005 · CIK: 0000891288 · Accession: 0000000000-05-047857

View on Edgar

AI Filing Summary & Sentiment

Date

September 16, 2005

Author

Kevin Woody

Form

UPLOAD

Company

QUESTCOR PHARMACEUTICALS INC (CIK 0000891288)

Letter

Mail Stop 6010 Via Facsimile and U.S. Mail September 16, 2005 Mr. James L. Fares President and Chief Executive Officer Questcor Pharmaceuticals, Inc. 3260 Whipple Road Union City, CA 94587

Re: Questcor Pharmaceuticals, Inc. Form 10-K for the fiscal year ended December 31, 2004 Filed March 31, 2005 File No. 1-14758

Dear Mr. Fares:

We have completed our review of your Form 10-K and have no further comments at this time.

Sincerely,
Kevin Woody
Branch Chief

Show Raw Text

<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

Mail Stop 6010
Via Facsimile and U.S. Mail

September 16, 2005

Mr. James L. Fares
President and Chief Executive Officer
Questcor Pharmaceuticals, Inc.
3260 Whipple Road
Union City, CA 94587

      Re:	Questcor Pharmaceuticals, Inc.
		Form 10-K for the fiscal year ended December 31, 2004
		Filed March 31, 2005
      File No. 1-14758

Dear Mr. Fares:

	We have completed our review of your Form 10-K and have no
further comments at this time.

								Sincerely,

      Kevin Woody
								Branch Chief

</TEXT>
</DOCUMENT>

SecProbe.io